(Q28243392)
Statements
The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants (English)
0 references
1 June 2006
0 references
66
0 references
11
0 references
5790-7
0 references